In support of mitochondrial replacement therapy

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1.

    Scientific Review of the Safety and Efficacy of Methods to Avoid Mitochondrial Disease through Assisted Conception (HFEA, 2011).

  2. 2.

    Scientific Review of the Safety and Efficacy of Methods to Avoid Mitochondrial Disease through Assisted Conception (HFEA, 2013).

  3. 3.

    Third Scientific Review of the Safety and Efficacy of Methods to Avoid Mitochondrial Disease through Assisted Conception : 2014 Update (HFEA, 2014).

  4. 4.

    Scientific Review of the Safety and Efficacy of Methods to Avoid Mitochondrial Disease through Assisted Conception : 2016 Update (HFEA, 2016).

  5. 5.

    Novel Techniques for the Prevention of Mitochondrial DNA Disorders: An Ethical Review (Nuffield Council on Bioethics, 2012).

  6. 6.

    The Human Fertilisation and Embryology (Mitochondrial Donation) Regulations No. 572 (HFEA, 2014).

  7. 7.

    United Kingdom, Parliament, House of Commons. Human fertilisation and embryology. Hansard, columns 160–187 (3 February 2015).

  8. 8.

    United Kingdom, Parliament, House of Lords. Human fertilisation and embryology (mitochondrial donation) regulations 2015. Hansard, columns 1569–1627 (24 February 2015).

  9. 9.

    Cellular, Tissue, and Gene Therapies Advisory Committee. Oocyte Modification in Assisted Reproduction for the Prevention of Transmission of Mitochondrial Disease or Treatment of Infertility Meeting No. 59 (FDA, 2014).

  10. 10.

    National Academies of Sciences, Engineering, and Medicine. Mitochondrial Replacement Techniques: Ethical, Social, and Policy Considerations (The National Academies Press, 2016).

  11. 11.

    Mitochondria Replacement Consultation: Advice to Government (HFEA, 2013).

  12. 12.

    Mitochondrial Donation: Government Response to the Consultation on Draft Regulations to Permit the Use of New Treatment Techniques to Prevent the Transmission of a Serious Mitochondrial Disease from Mother to Child (United Kingdom Department of Health, 2014).

  13. 13.

    HFEA permits cautious use of mitochondrial donation in treatment, following advice from scientific experts. HFEA https://www.hfea.gov.uk/about-us/news-and-press-releases/2016-news-and-press-releases/hfea-permits-cautious-use-of-mitochondrial-donation-in-treatment-following-advice-from-scientific-experts/ (2016).

  14. 14.

    HFEA statement on mitochondrial donation. HFEA https://www.hfea.gov.uk/about-us/news-and-press-releases/2017-news-and-press-releases/hfea-statement-on-mitochondrial-donation/ (2017).

  15. 15.

    Sherratt, S. Women selected for mitochondrial donation in UK. BioNews 936, 96351 (2018).

    Google Scholar 

  16. 16.

    United States Public Law no. 115–141. Consolidated Appropriations Act 2018 (23 March 2018).

Download references

Author information

Affiliations

Authors

Corresponding authors

Correspondence to Robert Cook-Deegan or Lori P. Knowles.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Adashi, E.Y., Caplan, A.L., Capron, A. et al. In support of mitochondrial replacement therapy. Nat Med 25, 870–871 (2019). https://doi.org/10.1038/s41591-019-0477-4

Download citation

Further reading

Search

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing